Zosano Pharma Corp 4/A
4/A · Zosano Pharma Corp · Filed May 26, 2017
Insider Transaction Report
Form 4/AAmended
WALKER JOHN PETER
Director
Transactions
- Purchase
Common Stock
2017-05-24$1.34/sh+36,166$48,553→ 169,344 total - Purchase
Common Stock
2017-05-25$1.37/sh+37,550$51,338→ 206,894 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.33 to $1.35, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.38, inclusive. The reporting person undertakes to provide to Zosano Pharma Corporation, any security holder of Zosano Pharma Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- [F3]This Amended Form 4 is being filed to revise Footnotes 1 and 2 of the original Form 4 to state that the shares were "purchased" and not "sold." This amendment corrects an administrative error.